1 |
NCT03350438 |
Not yet recruiting |
Participation in Occupations and Perception of Quality of Life, Comparing Adults With and Without PTSD |
- Post Traumatic Stress Disorder
|
|
Observational |
|
|
Other |
- Observational Model: Cohort
- Time Perspective: Cross-Sectional
|
- self reported quality of life
- Self Reported Dissociation
- self reported participation
- self reported ptsd symptoms
|
80 |
Male |
18 Years to 60 Years (Adult) |
NCT03350438 |
0023-17-ziv |
PTSD |
January 1, 2018 |
July 30, 2018 |
October 30, 2018 |
November 22, 2017 |
December 2, 2017 |
|
- Ziv Hospital
Safed, Galilee, Israel
|
2 |
NCT03191760 |
Recruiting |
Open Trial of Behavioral Activation and Social Engagement (BASE) for Posttraumatic Stress Disorder (PTSD) |
- Post-Traumatic Stress Disorder
|
- Behavioral: Behavioral Activation
|
Interventional |
Not Applicable |
- Seattle Institute for Biomedical and Clinical Research
- VA Puget Sound Health Care System
|
Other / U.S. Fed |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- PTSD Checklist-Military Version
- Medical Outcomes Study Social Support Survey Form and Social Connectedness Scale - Revised
- Patient Health Questionnaire-8
- (and 4 more...)
|
15 |
All |
18 Years and older (Adult, Senior) |
NCT03191760 |
00975 |
PTSD |
June 8, 2017 |
June 8, 2018 |
July 8, 2018 |
June 19, 2017 |
October 6, 2017 |
|
- VA Puget Sound Health Care System
Seattle, Washington, United States
|
3 |
NCT02727998 |
Recruiting |
Intensive 7-day Treatment for PTSD Combining Ketamine With Exposure Therapy |
- Posttraumatic Stress Disorder
|
- Drug: Ketamine
- Drug: Midazolam
|
Interventional |
Phase 2 |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change from baseline to 90 days post treatment in Clinician-Administered PTSD Scale scores
- Change from baseline to 90 days post treatment in Beck Depression Inventory (BDI-II)
|
40 |
All |
21 Years to 55 Years (Adult) |
NCT02727998 |
1509016530 23260 |
PTSD |
December 2015 |
December 2020 |
December 2022 |
April 5, 2016 |
January 9, 2018 |
|
- Yale University School of Medicine
New Haven, Connecticut, United States
|
4 |
NCT02869646 |
Recruiting |
Acupuncture for PTSD |
- Posttraumatic Stress Disorder
|
- Procedure: Procedure: Acupuncture
- Procedure: Procedure: Sham acupuncture
|
Interventional |
Not Applicable |
- VA Office of Research and Development
- Analydata, Inc
|
U.S. Fed / Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Participant)
- Primary Purpose: Treatment
|
- Change in PTSD symptom severity on the Clinician Administered PSTD Scale - CAPS 5 from before to after treatment
- Change in EMG eyeblink startle from before to after treatment
|
90 |
All |
18 Years to 55 Years (Adult) |
NCT02869646 |
CLNA-02-15F |
PTSD ACU |
April 5, 2018 |
February 1, 2021 |
September 30, 2021 |
August 17, 2016 |
April 11, 2018 |
|
- VA Long Beach Healthcare System, Long Beach, CA
Long Beach, California, United States
|
5 |
NCT03502564 |
Recruiting New |
Integrated Treatment for Co-occurring Eating Disorders and Posttraumatic Stress Disorder |
- PostTraumatic Stress Disorder
- Eating Disorder
|
- Behavioral: CBT for ED
- Behavioral: Concurrent CBT for ED and PTSD
|
Interventional |
Not Applicable |
- University Health Network, Toronto
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change in clinician-assessed PTSD symptoms
- Change in self-reported PTSD symptoms
|
40 |
All |
17 Years and older (Child, Adult, Senior) |
NCT03502564 |
REB# 15-8826-A |
|
September 1, 2015 |
September 30, 2018 |
March 30, 2019 |
April 18, 2018 |
April 18, 2018 |
|
- Eating Disorder Program; Toronto General Hospital; University Health Network
Toronto, Ontario, Canada
|
6 |
NCT03247179 |
Recruiting |
The Mobile PTSD Coach App in Acute Injury Survivors |
- Chronic Pain
- Acute Pain Due to Trauma
- Posttraumatic Stress Disorder
|
- Other: PTSD Coach mobile application
|
Interventional |
Not Applicable |
- University of Pittsburgh
- Palo Alto Veteran's Institute for Research
- University of Pittsburgh Clinical and Translational Science Institute
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- PTSD Checklist for DSM 5 (Diagnostic and Statistical Manual for Mental Disorders-5)
- Short Form of the Patient Reported Outcomes Measurement Information System (PROMIS) Pain Interference Scale
- Short Form of the PROMIS Pain Intensity Scale
|
67 |
All |
18 Years to 65 Years (Adult) |
NCT03247179 |
PRO16010595 |
|
September 19, 2017 |
June 2018 |
August 2018 |
August 11, 2017 |
September 20, 2017 |
|
- UPMC Presbyterian Hospital
Pittsburgh, Pennsylvania, United States - UPMC Mercy Hospital
Pittsburgh, Pennsylvania, United States
|
7 |
NCT03236467 |
Recruiting |
Neurohormonal Benefits of Exercise in Fibromyalgia and PTSD |
|
- Behavioral: Progressive Exercise Training
|
Interventional |
Early Phase 1 |
- VA Office of Research and Development
- VA Boston Healthcare System
|
U.S. Fed |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Fibromyalgia Impact Questionnaire-Revised
- Clinician Administered PTSD Scale -5
|
36 |
Female |
18 Years to 60 Years (Adult) |
NCT03236467 |
D2395-P 1I21RX002395-01A1 |
EXFMPTSD |
January 1, 2018 |
December 31, 2020 |
December 31, 2020 |
August 2, 2017 |
January 8, 2018 |
|
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Boston, Massachusetts, United States
|
8 |
NCT02545192 |
Not yet recruiting |
A Pilot Study of Low Field Magnetic Stimulation in PTSD: Three Daily Treatments |
- Post Traumatic Stress Disorder
|
- Device: Low Field Magnetic Stimulation
|
Interventional |
Phase 1 |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
|
- Change in depression
- Change in anxiety
- Improvement in core PTSD symptoms
- (and 2 more...)
|
24 |
All |
21 Years to 65 Years (Adult) |
NCT02545192 |
2015P001621 |
LFMS in PTSD |
September 2016 |
September 2018 |
September 2019 |
September 9, 2015 |
April 13, 2016 |
|
- McLean Hospital
Belmont, Massachusetts, United States
|
9 |
NCT02780635 |
Recruiting |
Use of Mobile Apps for Those With PTSD and Their Partners |
|
- Behavioral: Mobile App + Mailed Materials for managing stress associated with PTSD
- Behavioral: Mobile App for managing stress associated with PTSD
|
Interventional |
Not Applicable |
- VA Palo Alto Health Care System
|
U.S. Fed |
- Allocation: Randomized
- Intervention Model: Factorial Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Caregiver Burden
- Functional Well-Being
- Personal Health Questionnaire Depression Scale
- (and 8 more...)
|
200 |
All |
18 Years to 90 Years (Adult, Senior) |
NCT02780635 |
33003 |
|
December 2015 |
December 2017 |
December 2017 |
May 23, 2016 |
June 23, 2017 |
|
- VA Palo Alto Health Care System Menlo Park Division
Menlo Park, California, United States
|
10 |
NCT03019497 |
Not yet recruiting |
Cognitive-behavioral Therapy for Treatment of Post-traumatic Stress Disorder and Related Problems |
|
- Behavioral: Specific Modules
- Behavioral: Cognitive behavioral therapy
|
Interventional |
Not Applicable |
- Université de Montréal
- Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change from Baseline in Clinician-Administered PTSD Scale for DSM-5 (CAPS-5; Weathers et al., 2013)
- The Structured Clinical Interview (SCID-I; First, Spitzer, Gibbon & Williams, 1995)
- The Beck II Depression Inventory (BDI-II; Beck, Steer & Brown, 1996)
- (and 9 more...)
|
134 |
All |
18 Years to 70 Years (Adult, Senior) |
NCT03019497 |
365935 |
CBT-PTSD-RP |
January 2017 |
June 2021 |
December 2021 |
January 12, 2017 |
January 13, 2017 |
|
- Stephane Guay
Montreal, Quebec, Canada
|
11 |
NCT02586064 |
Recruiting |
Comparative Effectiveness of Two Treatments for Veterans With PTSD |
- Posttraumatic Stress Disorder
|
- Behavioral: Interpersonal Therapy for PTSD
- Behavioral: Prolonged Exposure
|
Interventional |
Not Applicable |
- VA Office of Research and Development
- Georgetown University
- Southeast Louisiana Veterans Health Care System
|
U.S. Fed / Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change in Inventory of Interpersonal Functioning (IIP)
- Change in Clinician Administered PTSD Scale (CAPS-5)
- Change in Patient Health Questionnaire (PHQ)
- (and 5 more...)
|
176 |
All |
18 Years and older (Adult, Senior) |
NCT02586064 |
D1783-R I01RX001783 |
|
September 1, 2016 |
December 31, 2019 |
December 31, 2019 |
October 26, 2015 |
January 26, 2018 |
|
- Southeast Louisiana Veterans Health Care System, New Orleans, LA
New Orleans, Louisiana, United States - Providence VA Medical Center, Providence, RI
Providence, Rhode Island, United States
|
12 |
NCT02685358 |
Recruiting |
An RCT of a Primary Care-Based PTSD Intervention: Clinician-Supported PTSD Coach |
- Posttraumatic Stress Disorder
|
- Behavioral: Clinician-Supported PTSD Coach
- Behavioral: Primary Care Mental Health Integrated Care as Usual
|
Interventional |
Not Applicable |
- VA Office of Research and Development
|
U.S. Fed |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Health Services Research
|
- Clinician Administered PTSD Scale for DSM-5 (CAPS-5)
- Hospital administrative data showing 2 mental health visits for PTSD completed
|
260 |
All |
18 Years and older (Adult, Senior) |
NCT02685358 |
IIR 14-288 HX-001790-1 |
|
March 1, 2017 |
February 29, 2020 |
September 30, 2020 |
February 18, 2016 |
December 15, 2017 |
|
- VA Palo Alto Health Care System, Palo Alto, CA
Palo Alto, California, United States - Syracuse VA Medical Center, Syracuse, NY
Syracuse, New York, United States
|
13 |
NCT03482466 |
Not yet recruiting New |
Neurofeedback for PTSD |
- Post-traumatic Stress Disorder
|
- Behavioral: Neurofeedback
|
Interventional |
Not Applicable |
- VA Office of Research and Development
- Baylor College of Medicine
|
U.S. Fed / Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- CAPS5 PTSD criteria
- Wearable device data: heart rate
- Wearable device data: sleep patterns
- Wearable device data: total sleep
|
12 |
All |
18 Years to 64 Years (Adult) |
NCT03482466 |
D2588-P |
NEUROFEEDPTSD |
May 1, 2018 |
July 25, 2018 |
February 28, 2020 |
March 29, 2018 |
March 29, 2018 |
|
- Michael E. DeBakey VA Medical Center, Houston, TX
Houston, Texas, United States
|
14 |
NCT02370173 |
Recruiting |
A Method for Enhancing Sleep in PTSD |
|
- Device: PTSD wavelength-1 bright light
- Device: PTSD wavelength-2 bright light
|
Interventional |
Not Applicable |
- University of Arizona
- U.S. Army Medical Research Acquisition Activity
|
Other / U.S. Fed |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Sleep Quality
- Neural activation during functional magnetic resonance imaging (fMRI) executive function task
- Performance on neuropsychological assessment
- (and 2 more...)
|
90 |
All |
18 Years to 50 Years (Adult) |
NCT02370173 |
1407389306A003 |
|
September 2014 |
December 2018 |
December 2018 |
February 24, 2015 |
April 17, 2018 |
|
- University of Arizona
Tucson, Arizona, United States
|
15 |
NCT03391297 |
Recruiting |
Shortened Prolonged Exposure Therapy for Chronic PTSD in Taiwanese Adults |
- Posttraumatic Stress Disorder
|
- Behavioral: Prolonged Exposure Therapy
|
Interventional |
Not Applicable |
- Chang Gung University
- Ministry of Science and Technology, Taiwan
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Interviewer-assessed PTSD diagnosis and symptoms
- Self-reported PTSD symptoms
- Self-reported depressive symptoms
- (and 2 more...)
|
8 |
All |
18 Years to 65 Years (Adult) |
NCT03391297 |
MOST 106-2628-H-182-001-SS2 |
|
January 10, 2018 |
November 30, 2018 |
November 30, 2018 |
January 5, 2018 |
January 8, 2018 |
|
- Graduate Institute of Behavioral Sciences, Chang Gung University
Taoyuan, Guishan Dist., Taiwan
|
16 |
NCT02945709 |
Recruiting |
Attention Control Treatment for Post Traumatic Stress Disorder ׂ(PTSD) |
|
- Behavioral: Personalized Attention control training (ACT)
- Behavioral: Non-personalized Attention control training (ACT)
- Behavioral: Control training.
|
Interventional |
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Factorial Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- A diagnosis of PTSD and a total score of severity symptoms, as driven from the CAPS-5 interview
- Total score of the PTSD Checklist (PCL-5).
|
60 |
All |
18 Years to 70 Years (Adult, Senior) |
NCT02945709 |
TAUPTSD |
|
October 2016 |
October 2018 |
December 2018 |
October 26, 2016 |
February 23, 2017 |
|
- Tel Aviv University
Tel Aviv, Israel
|
17 |
NCT02709018 |
Recruiting |
A Controlled Trial of Losartan in Posttraumatic Stress Disorder |
- Posttraumatic Stress Disorder
|
- Drug: losartan
- Drug: Placebo
|
Interventional |
Not Applicable |
- University of California, San Diego
- Mclean Hospital
- Massachusetts General Hospital
- (and 4 more...)
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- The primary outcome for this study is mean change in Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) over the treatment period of 10 weeks between the losartan arm and the placebo arm.
- Change in CAPS-5 associated with CC homozygosity for rs4311 SNP in the angiotensin converting enzyme gene (ACE) compared to T carriers, among subjects randomized to losartan.
|
160 |
All |
18 Years to 70 Years (Adult, Senior) |
NCT02709018 |
W81XWH-15-2-0090 |
LOSe-PTSD |
July 2016 |
September 2018 |
September 2019 |
March 15, 2016 |
February 28, 2018 |
|
- University of California, San Diego
La Jolla, California, United States - George Washington University
Washington, District of Columbia, United States - Atlanta Veterans Affairs Medical Center
Atlanta, Georgia, United States - (and 3 more...)
|
18 |
NCT02019940 |
Recruiting |
A Pilot Study Of Riluzole In Patients With Post Traumatic Stress Disorder (PTSD) |
|
|
Interventional |
Phase 1 |
- Yale University
- National Center for PTSD
|
Other / U.S. Fed |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Change in Clinician Administered PTSD Scale (CAPS)
- Post-Traumatic Stress Disorder Checklist (PCL)
- Clinical Global Impressions Scale
- Montgomery-Asberg Depression Rating Scale (MADRS)
|
20 |
All |
18 Years to 75 Years (Adult, Senior) |
NCT02019940 |
1308012549 |
|
January 2014 |
December 2018 |
December 2018 |
December 24, 2013 |
February 9, 2018 |
|
- Clinical Neuroscience Division, National Center for PTSD
West Haven, Connecticut, United States
|
19 |
NCT03110575 |
Recruiting |
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients |
|
|
Interventional |
Phase 3 |
- Tonix Pharmaceuticals, Inc.
- Premier Research Group plc
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Evaluate the incidence of adverse events of TNX-102 SL tablets taken daily at bedtime over an additional 12 weeks in patients with PTSD who have completed a double-blinded lead-in study
- Evaluate the change from both baselines in the Total CAPS-5 score of TNX-102 SL tablets taken daily at bedtime over an additional 12 weeks in patients with PTSD who have completed a double-blinded lead-in study
- Evaluate the proportion of patients with a CGI-I score of "very much improved" or "much improved" of TNX-102 SL tablets taken daily at bedtime over an additional 12 weeks in patients with PTSD who have completed a double-blinded lead-in study
|
420 |
All |
18 Years to 75 Years (Adult, Senior) |
NCT03110575 |
TNX-CY-P303 |
|
June 20, 2017 |
December 2018 |
December 2018 |
April 12, 2017 |
April 5, 2018 |
|
- Phoenix
Phoenix, Arizona, United States - Rogers
Rogers, Arkansas, United States - Beverly Hills
Beverly Hills, California, United States - (and 29 more...)
|
20 |
NCT03449576 |
Not yet recruiting |
Efficacy and Neural Mediators of Response to Trauma Management Therapy for PTSD |
|
- Other: Trauma Management Therapy
- Other: Exposure Therapy with Psychoeducation
|
Interventional |
Not Applicable |
- VA Office of Research and Development
|
U.S. Fed |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Prevention
|
- Change in Clinician-Administered PTSD Scale for DSM-5
- Change in Social Adjustment Scale - Self-Report
- Change in PTSD Checklist for DSM-5
- (and 2 more...)
|
132 |
All |
18 Years to 65 Years (Adult) |
NCT03449576 |
D2354-R |
|
July 1, 2018 |
July 1, 2022 |
July 1, 2022 |
February 28, 2018 |
February 28, 2018 |
|
- Salem VA Medical Center, Salem, VA
Salem, Virginia, United States
|
21 |
NCT03344471 |
Recruiting |
Factors Associated With Post-Traumatic Stress Disorder in Patients With After Preterm Delivery |
|
- Other: Passation of questionnaires
|
Interventional |
Not Applicable |
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Basic Science
|
- PPQ (Perinatal PTSD Questionnaire)
- NEO-FFI
|
60 |
Female |
18 Years and older (Adult, Senior) |
NCT03344471 |
PO17133 |
PTSD-preterm |
December 13, 2017 |
June 13, 2018 |
December 13, 2018 |
November 17, 2017 |
January 8, 2018 |
|
- Damien JOLLY
Reims, France
|
22 |
NCT03260127 |
Not yet recruiting |
Enhancement of PTSD Treatment With Computerized Executive Function Training |
- Posttraumatic Stress Disorder
|
- Behavioral: Computerized executive function training plus CPT (CEFT-CPT)
- Behavioral: Word game training plus CPT (WT-CPT)
|
Interventional |
Not Applicable |
- VA Office of Research and Development
|
U.S. Fed |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Care Provider, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Wisconsin Card Sorting Test (WCST)
- Paced Auditory Serial Addition Test (PASAT)
- Delis Kaplan Executive Function System (D-KEFS)
- (and 3 more...)
|
110 |
All |
18 Years to 55 Years (Adult) |
NCT03260127 |
F2459-W IK2RX002459 |
|
May 14, 2018 |
April 1, 2022 |
September 30, 2022 |
August 24, 2017 |
March 12, 2018 |
|
- VA San Diego Healthcare System, San Diego, CA
San Diego, California, United States
|
23 |
NCT01911585 |
Recruiting |
Efficacy of 60-minute Versus 90-minute Sessions in Treating PTSD Using Prolonged Exposure |
- Posttraumatic Stress Disorder
- PTSD
|
- Behavioral: Prolonged Exposure Therapy
|
Interventional |
Not Applicable |
- University of Pennsylvania
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change in PTSD Symptom Scale, Interview Version (PSS-I; Foa, Riggs, Dancu, & Rothbaum, 1993; Powers, Gillihan, Rosenfield, Jerud & Foa, 2012)
- Posttraumatic Diagnostic Scale (PDS; Foa et al., 1997)
- Beck Depression Inventory (BDI; Beck et al., 1961)
- Post-Traumatic Cognitions Inventory (PTCI; Foa et al., 1999)
|
60 |
All |
18 Years and older (Adult, Senior) |
NCT01911585 |
817717 |
|
July 2013 |
July 2019 |
July 2019 |
July 30, 2013 |
August 3, 2017 |
|
- Center for the Treatment and Study of Anxiety
Philadelphia, Pennsylvania, United States
|
24 |
NCT03256227 |
Recruiting |
Improving Veteran Adherence to Treatment for PTSD Through Partnering With Families |
- Posttraumatic Stress Disorder
|
- Behavioral: Family Supported Prolonged Exposure
- Behavioral: Standard Prolonged Exposure
|
Interventional |
Not Applicable |
- VA Office of Research and Development
|
U.S. Fed |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- session attendance
- PTSD Checklist for DSM-5 (PCL-5)
|
312 |
All |
18 Years and older (Adult, Senior) |
NCT03256227 |
IIR 15-322 |
|
January 15, 2018 |
December 31, 2020 |
February 26, 2021 |
August 21, 2017 |
February 5, 2018 |
|
- Atlanta VA Medical and Rehab Center, Decatur, GA
Decatur, Georgia, United States - VA Ann Arbor Healthcare System, Ann Arbor, MI
Ann Arbor, Michigan, United States - Minneapolis VA Health Care System, Minneapolis, MN
Minneapolis, Minnesota, United States
|
25 |
NCT03343028 |
Recruiting |
Biomarker Establishment for Superior Treatment of PTSD |
|
- Behavioral: Psychotherapy
|
Observational |
|
- Stanford University
- New Mexico VA Healthcare System
|
Other / U.S. Fed |
|
- Understanding the brain network function-neuroimaging and behavioral with Clinician-Administered PTSD Scale for DSM-5
|
260 |
All |
18 Years to 60 Years (Adult) |
NCT03343028 |
39006 |
|
September 2016 |
September 2019 |
September 2019 |
November 17, 2017 |
April 18, 2018 |
|
- VA Palo Alto Health Care System (VAPAHCS)
Palo Alto, California, United States - New Mexico VA Health Care System
Albuquerque, New Mexico, United States
|
26 |
NCT02925481 |
Recruiting |
Yoga Online Feasibility to Reduce PTSD |
|
- Behavioral: Moderate Online yoga participation
- Behavioral: Stretching and toning
- Behavioral: Low dose online yoga participation
|
Interventional |
Not Applicable |
- Arizona State University
- National Institutes of Health (NIH)
- National Center for Complementary and Integrative Health (NCCIH)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Participant)
- Primary Purpose: Treatment
|
- Clinically elevated levels of PTSD (according to IES-R)
|
90 |
Female |
18 Years and older (Adult, Senior) |
NCT02925481 |
R34AT008808 |
|
April 2016 |
June 2019 |
June 2019 |
October 6, 2016 |
October 6, 2016 |
|
- Arizona Biomedical Collaborative
Phoenix, Arizona, United States
|
27 |
NCT02576899 |
Recruiting |
Improving Functional Outcomes of Veterans With PTSD and Tobacco Dependence |
- Tobacco
- Posttraumatic Stress Disorder
|
- Behavioral: Acceptance and Commitment Therapy for PTSD and Tobacco Use
- Behavioral: Freedom From Smoking
|
Interventional |
Phase 1 |
- VA Office of Research and Development
|
U.S. Fed |
- Allocation: Randomized
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- 7-day point prevalence of smoking abstinence
- PTSD symptoms as measured by the PTSD Checklist for DSM 5
- Functional Impairment as measured by the The Short Form 36 Health Survey (SF-36)
- Quality of Life as measured by the Quality of Life Enjoyment and Satisfaction Questionnaire
|
50 |
All |
18 Years and older (Adult, Senior) |
NCT02576899 |
D1756-P 121RX-001756-01A1 |
ACT-PT |
September 1, 2015 |
March 30, 2018 |
March 30, 2018 |
October 15, 2015 |
March 14, 2018 |
|
- Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA
Bedford, Massachusetts, United States
|
28 |
NCT03216356 |
Recruiting |
Effect of D-cycloserine on a Short Imagery Rescripting Intervention for Subclinical PTSD |
|
- Behavioral: CBT + ImRs
- Behavioral: CBT + I.E.
- Drug: D-Cycloserine
- Drug: Placebo
|
Interventional |
Phase 2 Phase 3 |
- Boston University Charles River Campus
- James S McDonnell Foundation
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- The Clinician-Administered PTSD Scale (CAPS)
- PTSD Checklist for DSM-5 (PCL-5)
- Depression, Anxiety and Stress Scale (DASS-21)
- (and 4 more...)
|
60 |
Female |
18 Years and older (Adult, Senior) |
NCT03216356 |
4114 |
|
September 2016 |
December 2019 |
December 2020 |
July 13, 2017 |
July 13, 2017 |
|
- Center for Anxiety and Related Disorders at Boston University
Boston, Massachusetts, United States
|
29 |
NCT02199652 |
Recruiting |
Reducing Suicidal Ideation Through Treatment of Nightmares-Post Traumatic Stress Disorder (PTSD) |
- Post Traumatic Stress Disorder
- Suicidal Ideation
- Nightmares
|
- Drug: Prazosin
- Drug: Placebo
|
Interventional |
Phase 4 |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Participant)
- Primary Purpose: Treatment
|
- Change score for Scale for Suicide Ideation
|
10 |
All |
18 Years to 65 Years (Adult) |
NCT02199652 |
00001365 |
REST-ON PTSD |
March 2014 |
March 2017 |
March 2017 |
July 24, 2014 |
August 11, 2016 |
|
- Georgia Regents University
Augusta, Georgia, United States
|
30 |
NCT03375294 |
Recruiting |
Exploring Nitrous Oxide Effects for Post Traumatic Stress Disorder (PTSD) |
- Post Traumatic Stress Disorder
|
|
Interventional |
Phase 2 |
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Clinical Global Impression (CGI)
|
5 |
All |
18 Years to 65 Years (Adult) |
NCT03375294 |
41822 |
tN2O |
April 1, 2018 |
January 15, 2020 |
January 15, 2021 |
December 18, 2017 |
March 29, 2018 |
|
- Veterans Affairs Palo Alto
Palo Alto, California, United States
|
31 |
NCT03062540 |
Recruiting |
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD |
|
- Drug: TNX-102 SL
- Drug: Placebo SL Tablet
|
Interventional |
Phase 3 |
- Tonix Pharmaceuticals, Inc.
- Premier Research Group plc
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Mean change from baseline in the total Clinician Administered PTSD Scale (CAPS-5) for DSM-5 at Week 12.
- Clinical Global Impression - Improvement from Initiation of Treatment (CGI-I) score after 12 weeks of treatment.
- Change from baseline in the disruption of social life/leisure activities assessed using the Sheehan Disability Scale (SDS) after 12 weeks of treatment.
- (and 2 more...)
|
550 |
All |
18 Years to 75 Years (Adult, Senior) |
NCT03062540 |
TNX-CY-P301 |
HONOR |
March 27, 2017 |
October 2018 |
October 2018 |
February 23, 2017 |
January 10, 2018 |
|
- Phoenix
Phoenix, Arizona, United States - Little Rock
Little Rock, Arkansas, United States - Rogers
Rogers, Arkansas, United States - (and 41 more...)
|
32 |
NCT03316196 |
Not yet recruiting |
Cognitive Training for PTSD |
- Posttraumatic Stress Disorder
|
- Behavioral: COGENT COGNITIVE TRAINING
- Behavioral: Non training computer condition
|
Interventional |
Not Applicable |
- VA Office of Research and Development
|
U.S. Fed |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Clinician Administered PTSD Scale - reexperiencing
- Delis-Kaplan Executive Functioning System
- Reading Span fMRI task (baseline to week 8)
- (and 2 more...)
|
100 |
All |
21 Years to 55 Years (Adult) |
NCT03316196 |
MHBB-023-17S CX001600-01A1 |
|
April 16, 2018 |
July 29, 2022 |
September 30, 2022 |
October 20, 2017 |
April 13, 2018 |
|
- VA San Diego Healthcare System, San Diego, CA
San Diego, California, United States
|
33 |
NCT03110302 |
Recruiting |
In-Home Exposure Therapy for Veterans With Post Traumatic Stress Disorder (PTSD) |
- Posttraumatic Stress Disorder
|
- Behavioral: Prolonged exposure
|
Interventional |
Not Applicable |
- Veterans Medical Research Foundation
- United States Department of Defense
|
Other / U.S. Fed |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change in Clinician-Administered PTSD Scale for DSM-5 (CAPS-5)
- Change in Beck Depression Inventory (BDI-II)
- Change in PTSD Checklist (PCL-5)
- (and 3 more...)
|
175 |
All |
18 Years and older (Adult, Senior) |
NCT03110302 |
W81XWH-12- 1-0614 |
|
October 2012 |
June 2017 |
June 2017 |
April 12, 2017 |
April 12, 2017 |
|
- VA San Diego Healthcare System
San Diego, California, United States
|
34 |
NCT02492334 |
Recruiting |
Doxazosin for PTSD and Alcohol Use Disorder |
|
- Drug: Doxazosin
- Drug: Placebo
|
Interventional |
Phase 1 Phase 2 |
- Medical University of South Carolina
- Ralph H. Johnson VA Medical Center
|
Other / U.S. Fed |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- PTSD symptoms
- Alcohol use severity
- Characterize the underlying pathophysiology of comorbid PTSD/AUD and prognostic indicators of treatment responses
|
126 |
All |
21 Years to 65 Years (Adult) |
NCT02492334 |
3733318 |
|
July 2016 |
February 2019 |
March 2019 |
July 8, 2015 |
March 9, 2018 |
|
- Addiction Sciences Division-Medical University of South Carolina
Charleston, South Carolina, United States
|
35 |
NCT03039231 |
Recruiting |
Investigation of the Freespira Breathing System in the Treatment of Post Traumatic Stress Disorder (PTSD) |
- Stress Disorders, Post-Traumatic
|
- Device: Freespira Breathing System
|
Interventional |
Not Applicable |
- Palo Alto Health Sciences, Inc.
- VA Palo Alto Health Care System
|
Industry / U.S. Fed |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Primary outcome of this study will be quantitative improvements using the Clinician Administered PTSD Scale (CAPS - 5).
- Change in Patient Health Questionnaire (PHQ-9) Score
- Change in 36-Item Short Form Survey (SF-36) Score
- (and 3 more...)
|
55 |
All |
18 Years and older (Adult, Senior) |
NCT03039231 |
P-16-FS02 |
|
February 1, 2017 |
April 30, 2019 |
October 31, 2019 |
February 1, 2017 |
April 17, 2018 |
|
- Stanford University School of Medicine/Palo Alto Veterans Institute for Research
Palo Alto, California, United States
|
36 |
NCT02655692 |
Recruiting |
CAP-Ketamine for Antidepressant Resistant PTSD |
- PTSD
- Posttraumatic Stress Disorder
|
- Drug: Ketamine
- Drug: Placebo
|
Interventional |
Phase 2 |
- VA Office of Research and Development
- The University of Texas Health Science Center at San Antonio
- Brooke Army Medical Center
|
U.S. Fed / Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- PTSD Checklist to measure change in PTSD symptoms from baseline to post-treatment (4 weeks)
|
198 |
All |
18 Years to 70 Years (Adult, Senior) |
NCT02655692 |
SPLE-003-14W |
|
April 18, 2016 |
September 30, 2019 |
September 30, 2019 |
January 14, 2016 |
January 23, 2018 |
|
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT
West Haven, Connecticut, United States - Brooke Army Medical Center
San Antonio, Texas, United States
|
37 |
NCT02766192 |
Recruiting |
TIMBER Psychotherapy and Ketamine Single Infusion in Chronic PTSD |
|
- Drug: Ketamine
- Behavioral: TIMBER Psychotherapy
- Drug: Placebo (normal saline)
|
Interventional |
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change from baseline scores on the Clinician Administered PTSD Scale (CAPS) at 25th hours post-infusion
- Change from baseline scores on the PTSD Symptom Checklist (PCL, self-reported) at 25th hours post-infusion
- Change from baseline scores on the Hamilton depression rating scale (17-item version) at 25th hours post-infusion
- Change from baseline scores on the Beck Anxiety Scale at 25th hours post-infusion
|
50 |
All |
21 Years to 60 Years (Adult) |
NCT02766192 |
13-078 |
|
August 2013 |
December 2017 |
|
May 9, 2016 |
May 9, 2016 |
|
- Cooper University Hospital
Camden, New Jersey, United States
|
38 |
NCT02615197 |
Recruiting |
Effectiveness of PTSD Treatment For Suicidal and Multi-Diagnostic Clients |
- Post-traumatic Stress Disorder
- Suicide
- Self-injurious Behavior
|
- Behavioral: Dialectical Behavior Therapy
- Behavioral: Dialectical Behavior Therapy Prolonged Exposure protocol
|
Interventional |
Phase 2 Phase 3 |
- University of Washington
- National Institute of Mental Health (NIMH)
|
Other / NIH |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change from Baseline PTSD Severity at 12 months
- Global Severity of Illness
- Health-Related Quality of Life
- (and 3 more...)
|
75 |
All |
12 Years and older (Child, Adult, Senior) |
NCT02615197 |
49013 R34MH106598 |
|
February 2016 |
March 2019 |
March 2019 |
November 26, 2015 |
October 27, 2017 |
|
- Behavioral Research and Therapy Clinics, University of Washington
Seattle, Washington, United States
|
39 |
NCT03216434 |
Not yet recruiting |
Striatal Dopamine Transporter Density in Post-Traumatic Stress Disorder (PTSD) |
- Post-traumatic Stress Disorder
|
- Diagnostic Test: MRI using DaTscan
|
Interventional |
Not Applicable |
- St. Joseph's Hospital and Medical Center, Phoenix
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Diagnostic
|
- DaTscan intensity
- Quantifiable differences
- Striatal correlations
|
50 |
Male |
22 Years to 39 Years (Adult) |
NCT03216434 |
PHXB-17-0104-71-21 |
|
August 2017 |
August 2019 |
November 2019 |
July 13, 2017 |
July 13, 2017 |
|
|
40 |
NCT03348540 |
Recruiting |
Attention Control Training for PTSD in Children |
|
- Behavioral: Attention Control Training
- Behavioral: Comparison Task
|
Interventional |
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Care Provider)
- Primary Purpose: Treatment
|
- Change in posttraumatic stress disorder (PTSD) symptoms from pre to post test
|
60 |
All |
7 Years to 15 Years (Child) |
NCT03348540 |
1123267 |
|
November 20, 2017 |
November 20, 2020 |
November 20, 2020 |
November 21, 2017 |
November 21, 2017 |
|
- Creighton Univeristy
Omaha, Nebraska, United States
|
41 |
NCT03340350 |
Recruiting |
Minocycline for Treatment of Posttraumatic Stress Disorder in Veterans |
|
|
Interventional |
Phase 4 |
- Sriram Ramaswamy
- Creighton University
- VA Nebraska Western Iowa Health Care System
|
U.S. Fed / Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- PTSD Symptoms
- Change in C-reactive protein (CRP) level
- Change in interleukin 6 (IL-6) level
- (and 5 more...)
|
15 |
All |
19 Years to 65 Years (Adult) |
NCT03340350 |
RAM-01068 |
|
May 10, 2017 |
January 2018 |
January 2018 |
November 13, 2017 |
November 13, 2017 |
|
- VA Nebraska-Western Iowa Health Care System
Omaha, Nebraska, United States
|
42 |
NCT02290847 |
Recruiting |
Clinical Effectiveness Trial of In-Home Cognitive Processing Therapy for Combat-Related PTSD |
- Posttraumatic Stress Disorder
- PTSD
|
- Behavioral: Cognitive Processing Therapy (cognitive only version; CPT-C)
|
Interventional |
Not Applicable |
- The University of Texas Health Science Center at San Antonio
- Duke University
- VA Boston Healthcare System
- South Texas Veterans Health Care System
|
Other / U.S. Fed |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- PTSD Check List - DSM-5 (PCL-5), to assess change in PTSD symptomatology from baseline throughout treatment and at multiple follow up points
- Clinician-Administered PTSD Scale - 5 (CAPS-5); to assess change in PTSD symptomatology and/or diagnosis from baseline to multiple follow up points
|
123 |
All |
18 Years and older (Adult, Senior) |
NCT02290847 |
HSC20140055H |
|
September 2012 |
March 2018 |
March 2018 |
November 14, 2014 |
October 6, 2017 |
|
- Strong Star
San Antonio, Texas, United States
|
43 |
NCT02641496 |
Recruiting |
Cognitive Behavioral Therapy to Increase CPAP Adherence in Veterans With PTSD |
- Obstructive Sleep Apnea
- PTSD
- Posttraumatic Stress Disorder
|
- Behavioral: CBT-OSA
- Behavioral: Sleep Education
|
Interventional |
Not Applicable |
- VA Office of Research and Development
|
U.S. Fed |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Supportive Care
|
- Time in hours of "mask-on" CPAP usage per night
- Functional Outcomes of Sleep Questionnaire (FOSQ)
- California Verbal Learning Test, Second Edition (CVLT-II)
- PTSD Checklist for DSM-5 (PCL-5)
|
144 |
All |
18 Years to 99 Years (Adult, Senior) |
NCT02641496 |
D1799-R |
|
January 1, 2017 |
December 31, 2020 |
December 31, 2021 |
December 29, 2015 |
March 2, 2018 |
|
- VA Palo Alto Health Care System, Palo Alto, CA
Palo Alto, California, United States
|
44 |
NCT03350360 |
Recruiting |
Attention Control Training for PTSD Related to Combat or Interpersonal Violence |
|
- Behavioral: Attention Control Training
- Behavioral: Comparison Task
|
Interventional |
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Care Provider)
- Primary Purpose: Treatment
|
- Change in posttraumatic stress disorder (PTSD) symptoms from pre to post test
|
220 |
All |
19 Years to 80 Years (Adult, Senior) |
NCT03350360 |
1123259 |
|
November 17, 2017 |
November 17, 2020 |
November 17, 2020 |
November 22, 2017 |
November 22, 2017 |
|
- Creighton University
Omaha, Nebraska, United States
|
45 |
NCT02397889 |
Recruiting |
Repeated-Dose Intravenous Ketamine for PTSD |
- Posttraumatic Stress Disorder (PTSD)
|
- Drug: Ketamine
- Drug: Midazolam
|
Interventional |
Phase 2 Phase 3 |
- Icahn School of Medicine at Mount Sinai
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Clinician Administered PTSD Scale (CAPS)
- The Impact of Event Scale - Revised (IES-R)
- Montgomery Asberg Depression Rating Scale (MADRS)
- Patient-Rated Inventory of Side Effects (PRISE)
|
40 |
All |
18 Years to 65 Years (Adult) |
NCT02397889 |
GCO 15-0265 |
|
May 2015 |
December 2018 |
December 2018 |
March 25, 2015 |
January 11, 2018 |
|
- Mood and Anxiety Disorders Program (MAP)
New York, New York, United States
|
46 |
NCT02774642 |
Recruiting |
Integrated CBT-I and PE on Sleep and PTSD Outcomes (Impact Study) |
- Posttraumatic Stress Disorders
- Chronic Insomnia
|
- Behavioral: CBTI-PE
- Behavioral: Hygiene-PE
|
Interventional |
Not Applicable |
- VA Office of Research and Development
|
U.S. Fed |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change in PTSD Symptoms
- Change in Sleep Efficiency
- Change in Quality of Life
|
90 |
All |
19 Years and older (Adult, Senior) |
NCT02774642 |
D2120-W 1lK2Rx002120-01 |
|
October 1, 2016 |
March 31, 2021 |
September 30, 2021 |
May 17, 2016 |
January 25, 2018 |
|
- VA San Diego Healthcare System, San Diego, CA
San Diego, California, United States
|
47 |
NCT02372396 |
Recruiting |
Compassion Meditation for PTSD |
- Posttraumatic Stress Disorder
|
- Behavioral: Compassion Meditation (CM)
- Behavioral: Relaxation
|
Interventional |
Not Applicable |
- Veterans Medical Research Foundation
- National Center for Complementary and Integrative Health (NCCIH)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- Phase I (nonrandomized development): Multivariate intervention acceptability as measured by measures of credibility, satisfaction and adherence
- Phase 2 (randomized trial): PTSD severity as measured by the CAPS-5
|
40 |
All |
18 Years and older (Adult, Senior) |
NCT02372396 |
H130565 1R34AT007936-01A1 |
|
February 2015 |
December 2017 |
June 2018 |
February 26, 2015 |
October 20, 2017 |
|
- VA San Diego Healthcare System
San Diego, California, United States
|
48 |
NCT02391402 |
Recruiting |
Cognitively Augmented Behavioral Activation for Veterans With Comorbid TBI/PTSD |
- Traumatic Brain Injury
- Posttraumatic Stress Disorder
|
- Behavioral: Cognitively Augmented Behavioral Activation
- Behavioral: Treatment as Usual
|
Interventional |
Not Applicable |
- VA Office of Research and Development
|
U.S. Fed |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change in PTSD symptoms from baseline as measured by the Clinician Administered PTSD Scale - 5
- Change in PTSD symptoms from baseline as measured by the PTSD Checklist-5
- Change in postconcussion symptoms from baseline as measured by the Neurobehavioral Symptom Inventory
- (and 12 more...)
|
192 |
All |
18 Years to 55 Years (Adult) |
NCT02391402 |
D1189-I |
CABA |
May 4, 2015 |
November 30, 2018 |
March 18, 2019 |
March 18, 2015 |
April 18, 2018 |
|
- VA Portland Health Care System, Portland, OR
Portland, Oregon, United States - VA Puget Sound Health Care System Seattle Division, Seattle, WA
Seattle, Washington, United States
|
49 |
NCT03364192 |
Not yet recruiting |
Peer-Delivered Whole Health Coaching for Veterans With PTSD |
|
- Behavioral: Whole Health Coaching
|
Interventional |
Not Applicable |
- VA Office of Research and Development
- VA Center for Integrated Healthcare
|
U.S. Fed / Other |
- Allocation: Randomized
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Supportive Care
|
- Goal Attainment Scaling (GAS)
- PTSD Checklist for DSM-5 (PCL-5)
- Inventory of Psychosocial Functioning (IPF)
- Client Satisfaction Questionnaire
|
14 |
All |
18 Years and older (Adult, Senior) |
NCT03364192 |
D2476-M |
|
May 1, 2018 |
July 31, 2019 |
July 31, 2019 |
December 6, 2017 |
December 12, 2017 |
|
- Syracuse VA Medical Center, Syracuse, NY
Syracuse, New York, United States
|
50 |
NCT01995123 |
Recruiting |
Behavioral Activation for Smoking Cessation in PTSD |
|
- Behavioral: Behavioral Activation Therapy
- Behavioral: Health and Smoking Education
- Behavioral: Standard Smoking Cessation Therapy
|
Interventional |
Not Applicable |
- VA Office of Research and Development
- University of Wisconsin, Madison
|
U.S. Fed / Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Abstinence from tobacco
- Time to tobacco relapse
- PTSD symptoms
|
120 |
All |
18 Years and older (Adult, Senior) |
NCT01995123 |
MHBA-002-12F |
|
September 8, 2014 |
December 28, 2018 |
December 28, 2018 |
November 26, 2013 |
December 8, 2017 |
|
- William S. Middleton Memorial Veterans Hospital, Madison, WI
Madison, Wisconsin, United States
|